Zdrowie i gospodarka · 04/11/2013

FDA Proposes Rule to Require Manufacturers to Notify of Permanent Discontinuance or Interruption in Manufacturing of Certain Drugs or Biological Products

The FDA is proposing a rule that would require manufacturers of certain drugs or biological products to notify the agency electronically of a permanent discontinuance or interruption in manufacturing that may lead to a shortage of the product in the US, affecting blood or blood component transfusions.